Sector ratings Zealand Pharma A/S

Equities

Real-time Estimate Cboe Europe Other stock markets 06:26:57 2024-09-19 EDT			5-day change	1st Jan Change
925.25 ^DKK	+3.38%		+2.77%	+148.12%

09-09	Zealand Pharma's Weight Management Drug Shows Positive Topline Results in Early-stage Trial	MT
09-09	Zealand Pharma Weight Loss Treatment Trial Shows up to 8.3% Reduction in Body Weight	MT

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Composite Valuation	ESG Refinitiv	Capi. ($)
ZEALAND PHARMA A/S	-	B	9.47B
VERTEX PHARMACEUTICALS INCORPORATED		B+	124B
REGENERON PHARMACEUTICALS, INC.		B+	124B
ARGENX SE	-	B	31.62B
BIONTECH SE	-	B+	29.65B
BEIGENE, LTD.	-	B	21B
GENMAB A/S		A-	16.66B
WUXI APPTEC CO., LTD.		A-	16.12B
INSMED INCORPORATED	-	C	12.59B
NEUROCRINE BIOSCIENCES, INC.		C+	12.35B
SAREPTA THERAPEUTICS, INC.		C+	11.99B
LEGEND BIOTECH CORPORATION	-	D	9.37B
ASCENDIS PHARMA A/S	-	C+	8.41B
AKESO, INC.	-	B-	8.02B
EXELIXIS, INC.		B	7.87B
HALOZYME THERAPEUTICS, INC.		A-	7.85B
PHARMAESSENTIA CORPORATION		-	7.26B
Average		B	26.95B
Weighted average by Cap.		B